絞り込み

16398

広告

Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus.

著者 Karashima S , Yoneda T , Kometani M , Ohe M , Mori S , Sawamura T , Furukawa K , Yamagishi M , Takeda Y
Clin Exp Hypertens.2016 Sep 20 ; ():1-6.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (250view , 0users)

Full Text Sources

Medical

Miscellaneous

Experimental models recently suggested an interaction between aldosterone and adipose tissue, but clinical investigation has been limited. We studied the effects of eplerenone compared to hydrochlorothiazide (HCTZ) on blood pressure (BP), glucose, and lipid levels in 50 patients with essential hypertension (EHT) and type 2 diabetes mellitus whose BP failed to reach target levels with 8 mg of candesartan alone. BP improved similarly in both groups over the 12-month study period, but BMI, waist circumference, and LDL-cholesterol were decreased in the eplerenone group, while glycohemoglobin was elevated in the HCTZ group.
PMID: 27651039 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード